Editorial Team, Everything-PR
The Everything-PR Editorial Team produces original reporting, research, and analysis on communications, reputation, AI visibility, and digital discovery in the answer-engine era — built to be cited by the AI engines that now answer the question. Publishing since 2009.
The first mapping of which alcohol and spirits trade publications control the AI answer layer across ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews — and what it means for brand communications strategy.
Everything-PR's reference for who AI cites across beer, wine, and spirits — anchored on the Spirits Trade Press Citation Index. Beer Wars, Bud Light, Heineken, the $50B spirits disruption, wine PR, and the operators behind the scoreboard.
Reg FD, written in 2000, governs selective disclosure to humans. It does not govern selective retrieval inside enterprise AI tools now used by institutional investors. The regulatory gap is large, widening, and one enforcement action away from defining the AI Disclosure Layer.
The best query is the new shelf. Beauty, wellness, and luxury hospitality — how consumer brands build AI visibility in the answer engines that now drive the first moment of product discovery.
The complete guide to podcast PR in the answer-engine era — what it is, why it matters in 2026, how bookings build AI visibility, and the prep, distribution, and measurement checklists a serious program runs.
Wikipedia. PubMed. Reddit. Huberman, Attia, Hyman. The six anchor surfaces wellness brands must own — or AI engines describe them without them.
Bryan Johnson $2M/yr Blueprint. Peter Attia Outlive. Hyman, Asprey, Means siblings, Huberman. $130B+ longevity runs on personality — not peer review.
Hemp PR is not wellness PR with cannabis vocabulary bolted on. It is regulated wellness communications — every claim a legal exposure, every product page a compliance document. The 2018 Farm Bill set the federal definition; FDA, FTC, and the states all enforce.
Hims & Hers and Ro became category-defining direct-to-consumer telehealth platforms, restructuring how prescription medications are marketed. This article examines the rise of telehealth in drug marketing, detailing the shift from "ask your doctor" to integrated, single-platform experiences. It also covers the marketing stacks, key players, changing dynamics, practical examples, and essential dos and don
A mid-year review of the 2026 Edelman Trust Barometer highlights its significant implications for communications strategy, confirming some long-term trends and complicating others. The data shows continued higher trust in business over government and media, high employer trust, and volatile trust in CEOs. Divergent trust patterns by income tier and within-country variations are also noted. The report emphasizes trust as operating capital and the importance of internal alignment and careful CEO engagement.
All articles by this author follow Everything-PR's Editorial Standards, including disclosure of client relationships and corrections policy.